Terms: = Skin cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Treatment
19 results:
1. [Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor].
Lei JY; Li Y; Li CM; Xiong XL; Feng CC; Weng WJ; Peng XM; Zhou DH; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):445-449. PubMed ID: 38660850
[TBL] [Abstract] [Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
3. Adverse health outcomes among rural prostate cancer survivors: A population-based study.
Huang D; Chang CE; Newman M; Deshmukh V; Snyder J; Date A; Galvao C; Lloyd S; Henry NL; O'Neil B; Hashibe M
Cancer Epidemiol; 2023 Oct; 86():102430. PubMed ID: 37473579
[TBL] [Abstract] [Full Text] [Related]
4. IL-7R licenses a population of epigenetically poised memory CD8
Micevic G; Daniels A; Flem-Karlsen K; Park K; Talty R; McGeary M; Mirza H; Blackburn HN; Sefik E; Cheung JF; Hornick NI; Aizenbud L; Joshi NS; Kluger H; Iwasaki A; Bosenberg MW; Flavell RA
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2304319120. PubMed ID: 37459511
[TBL] [Abstract] [Full Text] [Related]
5. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure.
Qu R; Kluger Y; Yang J; Zhao J; Hafler DA; Krause DS; Bersenev A; Bosenberg M; Hurwitz M; Lucca L; Kluger HM
Mol Cancer; 2022 Dec; 21(1):219. PubMed ID: 36514045
[TBL] [Abstract] [Full Text] [Related]
6. Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Khushalani NI; Vassallo M; Goldberg JD; Eroglu Z; Kim Y; Cao B; Ferguson R; Monson KR; Kirchhoff T; Amato CM; Burke P; Strange A; Monk E; Gibney GT; Kudchadkar R; Markowitz J; Brohl AS; Pavlick A; Richards A; Woods DM; Weber J
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450385
[TBL] [Abstract] [Full Text] [Related]
7. Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution.
Li X; Zhao S; Bian X; Zhang L; Lu L; Pei S; Dong L; Shi W; Huang L; Zhang X; Chen M; Chen X; Yin M
Theranostics; 2022; 12(17):7532-7549. PubMed ID: 36438481
[No Abstract] [Full Text] [Related]
8. Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics.
Li G; Zhang J; Liu Y; Cheng X; Sun K; Hong W; Sha K
Comput Intell Neurosci; 2022; 2022():4493347. PubMed ID: 35300397
[TBL] [Abstract] [Full Text] [Related]
9. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
Zhang C; Dang D; Cong L; Sun H; Cong X
Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
[TBL] [Abstract] [Full Text] [Related]
10. Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.
Novik AV; Protsenko SA; Baldueva IA; Berstein LM; Anisimov VN; Zhuk IN; Semenova AI; Latipova DK; Tkachenko EV; Semiglazova TY
Oncologist; 2021 May; 26(5):364-e734. PubMed ID: 33749049
[TBL] [Abstract] [Full Text] [Related]
11. Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes.
Woods DM; Laino AS; Winters A; Alexandre J; Freeman D; Rao V; Adavani SS; Weber JS; Chattopadhyay PK
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369447
[TBL] [Abstract] [Full Text] [Related]
12. Decline of programmed death-1-positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade.
Gambichler T; Schröter U; Höxtermann S; Susok L; Stockfleth E; Becker JC
Br J Dermatol; 2020 May; 182(5):1214-1220. PubMed ID: 31361026
[TBL] [Abstract] [Full Text] [Related]
13. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim M; Yadav S; Ogunleye F; Zakalik D
BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Tang JY; Ally MS; Chanana AM; Mackay-Wiggan JM; Aszterbaum M; Lindgren JA; Ulerio G; Rezaee MR; Gildengorin G; Marji J; Clark C; Bickers DR; Epstein EH
Lancet Oncol; 2016 Dec; 17(12):1720-1731. PubMed ID: 27838224
[TBL] [Abstract] [Full Text] [Related]
15. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
[TBL] [Abstract] [Full Text] [Related]
16. Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.
Vence LM; Wang C; Pappu H; Anson RE; Patel TA; Miller P; Bassett R; Lizee G; Overwijk WW; Komanduri K; Benjamin C; Alvarado G; Patel SP; Kim K; Papadopoulos NE; Bedikian AY; Homsi J; Hwu WJ; Boyd R; Radvanyi L; Hwu P
J Immunother; 2013 May; 36(4):276-86. PubMed ID: 23603862
[TBL] [Abstract] [Full Text] [Related]
17. A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.
Ebert LM; MacRaild SE; Zanker D; Davis ID; Cebon J; Chen W
PLoS One; 2012; 7(10):e48424. PubMed ID: 23110239
[TBL] [Abstract] [Full Text] [Related]
18. Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2.
Bjoern J; Brimnes MK; Andersen MH; Thor Straten P; Svane IM
Scand J Immunol; 2011 Mar; 73(3):222-33. PubMed ID: 21204893
[TBL] [Abstract] [Full Text] [Related]
19. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract] [Full Text] [Related]
